USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-02-13 обновлены отчеты компании MEIP: 2023-Q42023-Q22022-Q4
MEI Pharma logo
MEI Pharma MEIP
$ 3.14 2.45%

MEI Pharma Мультипликаторы 2011-2024 | MEIP

Мультипликаторы по годам MEI Pharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.5 -0.1 -5.4 -5.8 -7.4 -3.8 40.7 -2.2 -1.4 -5.1 -6.8 -0.7 -2.4

P/S

1.0 0.1 6.5 9.8 25.2 93.7 4.7 - - - - - -

EPS

-4.8 -8.8 -0.4 -0.5 -0.2 -1.0 0.1 -0.6 -1.2 -1.4 -1.1 -0.6 -0.9

EV (Enterprise Value)

128 млн 113 млн 341 млн 392 млн 149 млн 193 млн 105 млн 41.5 млн 31.4 млн 128 млн 42 млн 1.1 млн 15.1 млн

EBITDA per Share

-5.46 -12.1 -0.53 -0.28 -0.649 -0.689 0.0671 -0.609 -1.16 -1.35 -1.1 -3.73 -5.05

EV/EBITDA

-5.7 -9.9 -2.5 -4.9 40.6 -1.7 -0.8 -4.5 -3.6 0.1 -2.0

PEG

-0.0 -0.0 0.02 0.02 -0.1 0.0 0.36 -0.05 -0.1 0.22 -0.1 -0.02 0.0

P/B

2.0 0.1 4.5 3.5 2.6 3.0 2.1 1.1 0.8 3.0 2.2 1.2 9.2

P/CF

-0.9 -0.1 -7.0 8.0 -4.2 -7.1 31.6 -2.6 -1.6 -7.0 -7.5 -0.8 -2.5

ROE %

-129.30 -103.89 -83.52 -61.22 -35.09 -79.41 5.25 -50.09 -54.68 -60.07 -32.08 -163.58 -377.98

ROA %

-26.35 -30.62 -23.73 -22.49 -20.35 -38.29 4.79 -44.23 -50.49 -54.51 -30.61 -118.04 -162.69

ROCE %

-149.30 -144.02 -122.15 -33.35 -67.65 -29.54 4.69 -50.43 -54.81 -60.25 -32.18 -182.52 -359.59

Current Ratio

1.3 1.4 1.4 1.6 5.7 13.2 11.4 8.5 13.0 10.7 21.5 3.6 1.7

DSO

- - - - 391.7 - - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - 1139.6 493.6 409.9 393.1 42.7 - - - - - -

Операционный цикл

- - - - 391.7 - - - - - - - -

Финансовый цикл

- - -1139.6 -493.6 -18.2 -393.1 -42.7 - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально MEI Pharma

2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.66 8.46 - -2.32 1.54 -2.49 -0.05 -1.31 -0.1 -0.16 -0.26 -0.11 -0.07 0.01 -0.1 -0.02 -0.26 -0.04 -0.26 -0.24 0.17 -0.21 0.17 -0.21 -0.16 -0.24 -0.16 -0.24 0.32 -0.12 0.32 -0.16 -0.15 -0.13 -0.15 -0.13 -0.39 -0.42 -0.39 -0.42 -0.32 -0.29 -0.32 -0.29 -0.5 -0.7 -0.5 -0.12 -0.78 -1.01 -0.13 -0.17

EBITDA per Share

-1.78 8.31 - - 1.35 -2.72 -1.37 -3.24 -0.14 -0.18 -0.32 -0.13 -0.14 -0.11 -0.17 -0.14 -0.15 -0.17 -0.15 -0.18 -0.17 -0.14 -0.17 -0.27 -0.16 -0.24 -0.16 -0.24 0.32 -0.12 0.32 -0.13 -0.15 -0.13 -0.15 -0.13 -0.39 -0.42 -0.39 -0.42 -0.32 -0.29 -0.32 -0.29 -0.51 -0.7 -0.5 -0.12 -0.99 -0.2 -0.44 -0.22

ROE %

-39.18 0.61 -68.30 -80.46 -48.39 -86.16 -92.65 -140.46 -178.64 -172.28 -136.82 -92.43 -43.92 -59.87 -70.44 -81.02 -84.81 -36.16 12.49 61.13 30.89 -7.45 -50.11 -88.44 -72.04 -34.54 -24.45 19.93 29.85 -1.68 0.15 -36.92 -34.40 -37.02 -52.67 -64.30 -76.47 -74.74 -66.54 -55.60 -43.60 -43.51 -118.22 -168.88 -214.56 -243.13 -200.76 -226.77 -263.05 -48.05 -85.90 -89.86

ROA %

18.58 39.61 -14.72 -18.30 -11.29 -24.04 -23.80 -34.38 -39.82 -37.96 -33.38 -24.68 -15.75 -30.69 -54.67 -73.66 -76.29 -44.93 -2.90 33.05 22.77 -3.67 -34.65 -57.06 -58.94 -24.57 -13.27 22.85 29.57 -0.12 -0.95 -34.02 -32.11 -34.26 -47.39 -57.80 -68.72 -67.64 -61.70 -52.20 -41.68 -41.32 -82.89 -117.31 -148.44 -167.97 -144.00 -137.76 -137.77 -32.61 -36.97 -38.68

ROCE %

-47.53 -9.03 -78.09 -95.82 -79.91 -122.39 -132.17 -190.72 -201.12 -197.16 -155.94 -105.79 -82.52 -78.12 -77.06 -66.60 -74.37 -80.86 -83.29 -89.78 -88.31 -82.25 -83.88 -77.81 -72.98 -35.36 -25.18 19.28 29.30 -2.16 -0.25 -37.19 -34.58 -37.17 -52.80 -64.41 -76.56 -74.86 -66.68 -64.71 -58.88 -58.75 -133.48 -175.20 -214.73 -253.89 -221.01 -377.92 -432.04 -57.62 -216.83 -107.75

Current Ratio

4.1 5.1 1.3 1.3 1.5 1.3 1.4 1.5 1.5 1.2 1.6 1.2 1.6 1.6 1.6 1.6 3.6 3.2 2.4 2.4 2.2 1.7 1.9 1.9 - - 11.4 - - 3.3 8.6 - - - - - - - - - - - - - - - 3.6 - - - 1.8 -

DSO

- - - - - - - - 38.6 58.8 23.3 34.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - 1580.2 1101.8 789.9 450.1 490.8 436.8 522.9 681.5 460.6 167.9 239.8 329.5 218.3 115.3 98.6 - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - 38.6 58.8 23.3 34.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - 38.6 58.8 23.3 -1546.1 -1101.8 -789.9 -450.1 -490.8 -436.8 -522.9 -681.5 -460.6 -167.9 -239.8 -329.5 -218.3 -115.3 -98.6 - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD